Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
BIRC6 encodes a protein with a BIR (baculoviral inhibition of apoptosis protein repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. De plus, nous expédions Baculoviral IAP Repeat-Containing 6 Kits (5) et et beaucoup plus de produits pour cette protéine.
Showing 10 out of 69 products:
Human Polyclonal BIRC6 Primary Antibody pour EIA, IHC (p) - ABIN1450019
Schimmer: Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. dans Cancer research 2004
Human Polyclonal BIRC6 Primary Antibody pour ELISA, WB - ABIN184895
Chen, Naito, Hori, Mashima, Yamori, Tsuruo: A human IAP-family gene, apollon, expressed in human brain cancer cells. dans Biochemical and biophysical research communications 1999
Dog (Canine) Monoclonal BIRC6 Primary Antibody pour IF, WB - ABIN968408
Hauser, Bardroff, Pyrowolakis, Jentsch: A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. dans The Journal of cell biology 1998
Results show that in addition to the scaffolding function in complex formation, BRUCE has an E3 ligase function to promote BRIT1 (Montrer MCPH1 Anticorps) deubiquitination by USP8 (Montrer USP8 Anticorps) leading to accumulation of BRIT1 (Montrer MCPH1 Anticorps) at DNA double-strand break.
BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and could be a potential target for colorectal cancer therapy.
The study demonstrates that the T allele of the rs2754511 in the BIRC6 gene plays a protective role in pseudoexfoliative glaucoma patients of the Pakistani population.
Humanin signaling pathway via htHNR/JAKs/STAT3 (Montrer STAT3 Anticorps) increased the expression levels of mRNA and protein of Apollon/Bruce, an unusual member of the inhibitors of apoptosis proteins
BRUCE acts as a scaffold, bridging the ubiquitin-specific peptidase 8 (USP8 (Montrer USP8 Anticorps)) and BRIT1 (Montrer MCPH1 Anticorps) in a complex to coordinate USP8 (Montrer USP8 Anticorps)-catalyzed deubiquitination of BRIT1 (Montrer MCPH1 Anticorps).
findings demonstrate that BIRC6 overexpression in hepatocellular carcinoma specimens is indicative of poor prognosis and that its interaction with p53 (Montrer TP53 Anticorps) facilitates the degradation of p53 (Montrer TP53 Anticorps)
The expression of BIRC6 in the cytoplasm is associated with epithelial ovarian cancer (EOC) differentiation and may be a novel predictor for poor prognosis of EOC patients after curative resection.
APPOLON to be a novel regulator of mitotic CYCLIN A (Montrer CCNA2 Anticorps) degradation independent of SAC (Montrer ADCY10 Anticorps).
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Knockdown experiments were performed using BIRC6 lentiviral shRNA and phenotype responses were analyzed by Western blot and MTT-assays.Upon silencing of BIRC6 by shRNA, DIABLO protein levels increased and cells went into apoptosis.
The results of this study reveal the importance of BIRC6 expression for embryo survival during bovine preimplantation embryo development.
BRUCE protects cells against apoptosis and functions as an inhibitor of apoptosis.
BRUCE is broadly expressed in embryonic, extraembryonic, and adult mouse tissues, this bifunctional protein might play a unique role in normal trophoblast differentiation and embryonic survival
p53 (Montrer TP53 Anticorps) is a downstream effector of Bruce, and, in response to loss of Bruce function, p53 (Montrer TP53 Anticorps) activates Pidd (Montrer PIDD Anticorps)/caspase-2 (Montrer CASP2 Anticorps) and Bax (Montrer BAX Anticorps)/Bak (Montrer BAK1 Anticorps), leading to mitochondrial apoptosis
Birc6 plays a role in cell division
These results establish a previously unrecognized link between NFAT (Montrer NFATC1 Anticorps) signaling and regulation of IAP (Montrer ALPI Anticorps) expression and are the first to identify a signaling pathway that increases BRUCE expression.
This gene encodes a protein with a BIR (baculoviral inhibition of apoptosis protein repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. This protein inhibits apoptosis by facilitating the degradation of apoptotic proteins by ubiquitination.
baculoviral IAP repeat-containing 6 (apollon)
, baculoviral IAP repeat-containing 6
, BIR repeat-containing ubiquitin-conjugating enzyme
, baculoviral IAP repeat-containing protein 6
, ubiquitin-conjugating BIR domain enzyme apollon
, ubiquitin-conjugating BIR-domain enzyme apollon
, baculovirus inhibitor of apoptosis repeat containing ubiquitin-conjugating enzyme
, baculovirus inhibitor of apoptosis repeat containing ubiquitin-conjugating enzyme; accccbaculoviral IAP repeat-containing 6